BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37264361)

  • 21. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.
    Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB
    Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of anthropometric indices with the development of multimorbidity in middle-aged and older adults: A retrospective cohort study.
    Geng S; Chen X; Shi Z; Bai K; Shi S
    PLoS One; 2022; 17(10):e0276216. PubMed ID: 36240163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of abdominal obesity measures in predicting of 10-year cardiovascular risk in an Iranian adult population using ACC/AHA risk model: A population based cross sectional study.
    Hajian-Tilaki K; Heidari B
    Diabetes Metab Syndr; 2018 Nov; 12(6):991-997. PubMed ID: 29937421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Waist-to-height ratio, waist circumference, body mass index, waist divided by height
    Lu Y; Liu S; Qiao Y; Li G; Wu Y; Ke C
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2644-2651. PubMed ID: 34226121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cut-off points for anthropometric indices to screen for hypertension among Iranian adults of the Bandare-Kong cohort: a cross-sectional study.
    Azarbad A; Aghnia T; Gharibzadeh A; Rafati S; Hashemi SM; Zarei H; Kheirandish M
    BMC Public Health; 2022 Nov; 22(1):2064. PubMed ID: 36369024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.
    Lopez-Rodriguez JA; Rogero-Blanco E; Aza-Pascual-Salcedo M; Lopez-Verde F; Pico-Soler V; Leiva-Fernandez F; Prados-Torres JD; Prados-Torres A; Cura-González I;
    PLoS One; 2020; 15(8):e0237186. PubMed ID: 32785232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysis.
    Menditto E; Gimeno Miguel A; Moreno Juste A; Poblador Plou B; Aza Pascual-Salcedo M; Orlando V; González Rubio F; Prados Torres A
    PLoS One; 2019; 14(2):e0210701. PubMed ID: 30726245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population.
    Hadaegh F; Zabetian A; Sarbakhsh P; Khalili D; James WP; Azizi F
    Int J Obes (Lond); 2009 Dec; 33(12):1437-45. PubMed ID: 19752876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Life-course socioeconomic conditions, multimorbidity and polypharmacy in older adults: A retrospective cohort study.
    Jungo KT; Cheval B; Sieber S; Antonia van der Linden BW; Ihle A; Carmeli C; Chiolero A; Streit S; Cullati S
    PLoS One; 2022; 17(8):e0271298. PubMed ID: 35917337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimorbidity Clusters in the Oldest Old: Results from the EpiChron Cohort.
    Ioakeim-Skoufa I; Clerencia-Sierra M; Moreno-Juste A; Elías de Molins Peña C; Poblador-Plou B; Aza-Pascual-Salcedo M; González-Rubio F; Prados-Torres A; Gimeno-Miguel A
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns and Predictors of Multimorbidity in the Azar Cohort.
    Somi M; Ostadrahimi A; Gilani N; Haji Kamanaj A; Hassannezhad S; Faramarzi E
    Arch Iran Med; 2023 Jan; 26(1):8-15. PubMed ID: 37543916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Smoking with General and Abdominal Obesity: Evidence from a Cohort Study in West of Iran.
    Rezaei S; Hajizadeh M; Pasdar Y; Hamzeh B; Moradinazar M; Najafi F
    J Res Health Sci; 2017 Dec; 18(1):e00401. PubMed ID: 29445047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between obesity-related anthropometric indices and multimorbidity among older adults in Shandong, China: a cross-sectional study.
    Zhang J; Xu L; Li J; Sun L; Qin W
    BMJ Open; 2020 May; 10(5):e036664. PubMed ID: 32430453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polypharmacy and Multimorbidity in the Urogynecology Population and Their Effect on Pelvic Floor Symptoms.
    Zuo SW; Tellechea L; Kohn JR; Chen CCG; Abraham N; Leegant A; Halani PK; Laudano M
    Urogynecology (Phila); 2023 Jan; 29(1):80-87. PubMed ID: 36548108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and Predicting Risk Factors of Polypharmacy in Azar Cohort Population.
    Gharekhani A; Somi M; Ostadrahimi A; Hatefi A; Haji Kamanaj A; Hassannezhad S; Faramarzi E
    Iran J Pharm Res; 2022 Dec; 21(1):e126922. PubMed ID: 36060920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polypharmacy and Multimorbidity Among Medicaid Enrollees: A Multistate Analysis.
    Feng X; Tan X; Riley B; Zheng T; Bias T; Sambamoorthi U
    Popul Health Manag; 2018 Apr; 21(2):123-129. PubMed ID: 28683221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of primary care structures with polypharmacy and patient-reported indicators in patients with complex multimorbidity: a multicentre cross-sectional study in Japan.
    Aoki T; Fujinuma Y; Matsushima M
    BMJ Open; 2022 Jan; 12(1):e054348. PubMed ID: 34996796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polypharmacy and specific comorbidities in university primary care settings.
    Aubert CE; Streit S; Da Costa BR; Collet TH; Cornuz J; Gaspoz JM; Bauer D; Aujesky D; Rodondi N
    Eur J Intern Med; 2016 Nov; 35():35-42. PubMed ID: 27289492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in Multimorbidity and Polypharmacy Patterns in Young and Adult Population over a 4-Year Period: A 2011-2015 Comparison Using Real-World Data.
    Mucherino S; Gimeno-Miguel A; Carmona-Pirez J; Gonzalez-Rubio F; Ioakeim-Skoufa I; Moreno-Juste A; Orlando V; Aza-Pascual-Salcedo M; Poblador-Plou B; Menditto E; Prados-Torres A
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33919351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and outcomes of polypharmacy in chronic obstructive pulmonary disease patients: A cross-sectional study from Crete, Greece.
    Ierodiakonou D; Theodorou E; Sifaki-Pistolla D; Bouloukaki I; Antonopoulou M; Poulorinakis I; Tsakountakis N; Voltiraki F; Chliveros K; Tsiligianni I
    Clin Respir J; 2021 Dec; 15(12):1310-1319. PubMed ID: 34425633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.